August 14, 2022
TrendRadars > Podcasts > Rational's Experimental Herpes Vaccine Shows Preclinical Promise
Rational's Experimental Herpes Vaccine Shows Preclinical Promise
Rational Vaccines said findings from a pilot study showed that RVX201 led to a reduction in recurrent genital lesions when compared to gD2-alum/MPL vaccine in animal studies.

Rational's Experimental Herpes Vaccine Shows Preclinical Promise

Rational Vaccines said findings from a pilot study showed that RVX201 led to a reduction in recurrent genital lesions when compared to gD2-alum/MPL vaccine in animal studies.

Leave a Reply